DDD 2024 Highlights Podcast

In this episode (15:44 min), Medicom’s correspondent covers the highlights from the Dutch Dermatology Days 2024, held in Amsterdam, the Netherlands, from 11-12 April.

A wide range of topics was discussed to inform and educate dermatologists on the latest insights in the field, including:

1. Are dermatologists to be replaced by Artificial Intelligence?
   Tobias Sangers (Leiden University Medical Centre, the Netherlands) shared some of the latest evidence with respect to AI in dermatology and explained in which ways it can be of use for dermatologists, now and in the future.
2. Safety and efficacy of a therapeutic HPV vaccine in high-grade AIN
   A therapeutic HPV-16 vaccine appeared to be safe in a population of HIV-positive men who have sex with men with high-grade anal intraepithelial neoplasia (AIN). In the highest dose group, the clinical response rate was 40%.
3. Developments in gene therapy for epidermolysis bullosa
   Gene therapy is an exciting field in medicine and novel options have been emerging for patients with epidermolysis bullosa (EB). Dr Peter van den Akker (University Medical Centre Groningen, the Netherlands) provided an overview of the latest advancements.
4. Improving risk classification in cutaneous SCC
   The latest guidelines on cutaneous squamous cell carcinoma (SCC) differentiate between staging systems and risk classification. According to the latest evidence, what is the metastatic risk for patients with SCC? And how can we estimate this risk accurately in the population of patients with SCC?

Enjoy listening!

Copyright ©2024 Medicom Medical Publishers



Posted on 6 May 202427 June 2024